SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,140 | -38.9% | 2,000 | -33.3% | 0.03% | -36.4% |
| Q2 2023 | $90,180 | -17.0% | 3,000 | 0.0% | 0.04% | -24.1% |
| Q1 2023 | $108,690 | +1.6% | 3,000 | 0.0% | 0.06% | -6.5% |
| Q4 2022 | $107,010 | +4.9% | 3,000 | 0.0% | 0.06% | +3.3% |
| Q3 2022 | $102,000 | +17.2% | 3,000 | 0.0% | 0.06% | +11.1% |
| Q2 2022 | $87,000 | -10.3% | 3,000 | 0.0% | 0.05% | +12.5% |
| Q1 2022 | $97,000 | +11.5% | 3,000 | 0.0% | 0.05% | +17.1% |
| Q4 2021 | $87,000 | +8.8% | 3,000 | 0.0% | 0.04% | -18.0% |
| Q3 2021 | $80,000 | -13.0% | 3,000 | 0.0% | 0.05% | -10.7% |
| Q2 2021 | $92,000 | +16.5% | 3,000 | 0.0% | 0.06% | -3.4% |
| Q1 2021 | $79,000 | +5.3% | 3,000 | 0.0% | 0.06% | -6.5% |
| Q4 2020 | $75,000 | +19.0% | 3,000 | 0.0% | 0.06% | 0.0% |
| Q3 2020 | $63,000 | – | 3,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |